Articles
27. 10. 2015 Cancer in the older population of the Czech Republic
Population ageing has become a challenge to cancer care in developed countries. Particularities of the older population must be taken into account when considering cancer treatment. However, there is a lack of consensus on guidelines for this population due to the underrepresentation of older patients in clinical trials.
15. 1. 2014 Personalised invitations of Czech citizens to cancer screening programmes
In January 2014, a project of personalised invitations for cancer screening programmes was launched in the Czech Republic. In particular, citizens are invited to participate in colorectal cancer screening (men and women), as well as breast cancer screening and cervical cancer screening (women). Personalised invitations are aimed at citizens who have not participated in cancer screening programmes in the long term, and therefore are at a higher risk of developing cancer. The project is expected to increase participation rates in Czech cancer screening programmes.
» Archive
Detail KOC
Comprehensive Cancer Centre of Hospital AGEL Novy Jicin, JSC
- Identification data
- Basic characteristics
- Contractual relationships with health insurance companies
- Hospital and management information systems
- Healthcare quality assessment and documentation
- clinical assessment
Identification data
| Official title of CCC: | Comprehensive Cancer Centre of Hospital AGEL Novy Jicin, JSC |
| Head of the centre: | Assoc. Prof. David Vrána, M.D., Ph.D. |
| Title of healthcare facility: | Hospital AGEL Novy Jicin, JSC |
| Director of the healthcare facility: | Jakub Fejfar, M.D., LL.M. |
| City: | Nový Jičín |
Cooperating healthcare facilities, clinics and departments including contact data:
| Name of clinic/department: | Department of Radiation Oncology, Hospital AGEL Novy Jicin, JSC |
| Head: | Marcel Matzenauer, M.D., Ph.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 416 180 |
| e-mail: | marcel.matzenauer@nnj.agel.cz |
| Name of clinic/department: | Department of Medical Oncology, Hospital AGEL Novy Jicin, JSC |
| Head: | Viktor Maňásek, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 562 |
| e-mail: | viktor.manasek@nnj.agel.cz |
| Name of clinic/department: | Department of Radiology and Imaging Methods, Hospital AGEL Novy Jicin, JSC |
| Head: | Marek Velkoborský, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 502 |
| e-mail: | marek.velkoborsky@nnj.agel.cz |
| Name of clinic/department: | Gastroenterology Outpatient Department, Hospital AGEL Novy Jicin, JSC |
| Head: | Martin Merenda, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 236 |
| e-mail: | martin.merenda@nnj.agel.cz |
| Name of clinic/department: | Department of Surgery, Hospital AGEL Novy Jicin, JSC |
| Head: | Matěj Škrovina, M.D., Ph.D., FEARCS |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 138 |
| e-mail: | matej.skrovina@nnj.agel.cz |
| Name of clinic/department: | Department of Gynaecology and Obstetrics, Hospital AGEL Novy Jicin, JSC |
| Head: | Martin Trhlík, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 284 |
| e-mail: | martin.trhlik@nnj.agel.czM |
| Name of clinic/department: | Department of Urology, Hospital AGEL Novy Jicin, JSC |
| Head: | Jan Novák, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 610 |
| e-mail: | jan.novak@nnj.agel.cz |
| Name of clinic/department: | Department of Pneumology, Hospital AGEL Novy Jicin, JSC |
| Head: | Ľubomír Leškovský, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 544 |
| e-mail: | lubomir.leskovsky@nnj.agel.cz |
| Name of clinic/department: | Department of Dermatology, Hospital AGEL Novy Jicin, JSC |
| Head: | Jana Chlebková, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 538 |
| e-mail: | jana.chlebkova@nnj.agel.cz |
| Name of clinic/department: | Department of ENT, Head and Neck Surgery, Hospital AGEL Novy Jicin, JSC |
| Head: | Jakub Syrovátka, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 637 |
| e-mail: | jakub.syrovatka@nnj.agel.cz |
| Name of clinic/department: | Department of Nuclear Medicine (PET Centre), Hospital AGEL Novy Jicin, JSC |
| Head: | Cyril Vojtek, M.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 773 104 |
| e-mail: | cyril.vojtek@nnj.agel.cz |
| Name of clinic/department: | Oncology Outpatient Department, Hospital AGEL Novy Jicin, JSC |
| Head: | Assoc. Prof. David Vrána, M.D., Ph.D. |
| Address: | Purkyňova 2138/16, 741 01 Nový Jičín |
| Phone: | +420 556 416 180 |
| e-mail: | david.vrana@nnj.agel.cz |
| Name of clinic/department: | Oncology Outpatient Department Karvina |
| Head: | Assoc. Prof. David Vrána, M.D., Ph.D. |
| Address: | Zakladatelská 975/22, 735 06 Karviná, Nové Město |
| Phone: | +420 596 380 650 |
| e-mail: | david.vrana@nnj.agel.cz |
| Name of clinic/department: | Oncology Outpatient Department Ostrava-Vitkovice |
| Head: | Assoc. Prof. David Vrána, M.D., Ph.D. |
| Address: | Zalužanského 1192/15, 703 00 Ostrava-Vítkovice |
| Phone: | +420 595 633 396 |
| e-mail: | david.vrana@radioterapie.cz |
| Name of clinic/department: | AGEL Diagnostic Centre Ltd. |
| Head: | Borek Frydrych, M.D. |
| Address: | Dvořákova 2211/27, 741 01 Nový Jičín |
| Phone: | +420 800 266 666 |
| e-mail: | recepce@ndc.agel.cz |
| Name of clinic/department: | AGEL Laboratories, JSC |
| Head: | Tomáš Gucký, Ph.D. |
| Address: | Revoluční 2214/35, 741 01 Nový Jičín |
| Phone: | +420 556 416 170 |
| e-mail: | sekretariat@lab.agel.cz |
Data authorization: 4. 6. 2025, MUDr. Jakub Fejfar, LL.M.
Basic characteristics
Beds and outpatient departments:
| Total number of beds available for cancer patients: | 30 |
| Total number of oncology outpatient departments: | 15 |
Medical equipment:
 Spiral computed tomography:
|
 MRI:
|
|
 PET:
|
 Classical mammography machine
|
|
 Digital mammography machine:
|
 Endoscopic ultrasound (EUS):
|
|
Other equipment:
Data authorization: 4. 6. 2025, MUDr. Jakub Fejfar, LL.M.
Contractual relationships with health insurance companies
Contractual relationships with healthcare payers:
| 111 - Všeobecná zdravotní pojišťovna ČR |  |
| 201 - Vojenská zdravotní pojišťovna ČR | |
| 205 - Česká průmyslová zdravotní pojišťovna | |
| 207 - Oborová zdravotní pojišťovna zaměstnanců bank, pojišťoven a stavebnictví | |
| 209 - Zaměstnanecká pojišťovna Škoda | - |
| 211 - Zdravotní pojišťovna ministerstva vnitra ČR | |
| 213 - Revírní bratrská pokladna, zdravotní pojišťovna | |
Data authorization: 4. 6. 2025, MUDr. Jakub Fejfar, LL.M.
Hospital and management information systems (HIS and MIS)
For the documentation of diagnostic and therapeutic processes in cancer patients, the centre employs a fully electronic Hospital Information System (HIS):
| HIS identification: | IKIS® |
| HIS provider: | Medical Systems a.s. |
The HIS employed in the centre enables a parametric collection of cancer data, at least in the extent of the report sent to the National Cancer Registry:
| Parametrization only in the extent of the report sent to the National Cancer Registry: | |
| Parametrization includes records beyond the report sent to the National Cancer Registry: | |
Which of the following data are parametrically recorded within the HIS and which of them are easily available for the centre's management:
| Data | Údaj parametricky zaznamenáván v NIS |
Údaj pohodlně dostupný pro vedení centra |
| Total number of diagnosed and/or treated patients | |
- |
| Number of diagnosed and/or treated patients sorted by diagnoses | |
- |
| Staging at the time of diagnosis (TNM, clinical stage etc.) | |
- |
| Results of histopathological examination (pTNM, grade etc.) | |
- |
| Results of laboratory examination | |
- |
| Results of examination by imaging methods | |
- |
| Records on anticancer pharmacotherapy (regimens, products, doses etc.) | |
- |
| Records on radiation therapy | |
- |
| Records on adverse drug reactions | |
- |
The centre employs a Management Information System (MIS):
| MIS identification: | |
| MIS provider: | |
| Length of use (in months): |
- |
The centre employs filmless technologies and telemedicine tools:
| HIS identification : | ePACS |
| HIS provider: | Medoro |
The centre employs an information system controlling the preparation of anticancer pharmacotherapy:
| The system enables a central drug preparation: | |
| The system allows an on-line ordering of pharmacotherapy: | |
Data authorization: 4. 6. 2025, MUDr. Jakub Fejfar, LL.M.
Healthcare quality assessment and documentation
The documentation of diagnostic and therapeutic processes in cancer patients is maintained:
in an existing Hospital Information System (HIS) with text records prevailing over parametric records
Documentation status of diagnostic and therapeutic processes in cancer patients:
A complete documentation is easily available on cancer patients - including the findings of examination by imaging methods either in classical or digital form, and archived histological material:
Informed consents of cancer patients are archived and available:
Documentation on all stages of anticancer therapy - i.e. operation protocols, records on radiation therapy and chemotherapy - is maintained in line with specific standards and easily available:
The centre is interested in the evaluation of its cancer diagnostics and treatment, using self-evaluation and local programmes aimed at healthcare quality check, if appropriate methodology is available:
The centre is interested in the electronic version of cancer patients' case report forms:
For the following reason: The centre is rebuilding its current system of data collection within the HIS
The centre follows recommended guidelines (standards) of cancer diagnostics and therapy:
The centre has its own system to monitor diagnostic and therapeutic standards:
Data authorization: 4. 6. 2025, MUDr. Jakub Fejfar, LL.M.
Clinical trials and implementation of new procedures
The centre has a local ethical commision at its disposal:
The centre is willing and has the capacity to take part in new multicentre clinical trials and registries:
Number of clinical trials (being conducted in compliance with the Good Clinical Practice) in which the centre currently participates:
| Phase I: |
Total number: 0 Number of international projects: 0 |
| Phase II: |
Total number: 1 Number of international projects: 1 |
| Phase III: |
Total number: 14 Number of international projects: 14 |
| Phase IV: |
Total number: 0 Number of international projects: 0 |
The centre is involved in Czech or international clinical registries:
(out of National Cancer Registry, i.e. projects concerned with genetics etc.)
| Project title | Identification of project organizers | Diagnosis of registered patients | The centre has been actively participating in the registry since |
| klinické registry ČOS ČLS JEP | IBA MU | C18-21, C50, C56, C64 | 2005 |
The centre actively participates in prevention programmes:
Primary prevention:
Secondary prevention:
The centre organizes its own projects of a nationwide significance in the following areas:
| Diagnostics: | pathology: radiodiagnostics: nuclear medicine: |
|
| Therapy: | chemotherapy: radiation therapy: biological therapy: |
|
Genomics and proteomics:
Pharmacogenetics:
Data authorization: 4. 6. 2025, MUDr. Jakub Fejfar, LL.M.
